iBio
IBIO
#10469
Rank
NZ$70.6 M
Marketcap
NZ$1.42
Share price
4.06%
Change (1 day)
-53.79%
Change (1 year)

EPS for iBio (IBIO)

EPS in 2026 (TTM): NZ-$1.31

According to iBio's latest financial reports the company's current EPS (TTM) is NZ-$1.33. In 2025 the company made an earnings per share (EPS) of NZ-$3.11 an increase over its 2024 EPS that were of NZ-$11.55.

EPS history for iBio from 2007 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$1.31-57.75%
2025NZ-$3.11-73.08%
2024NZ-$11.55-93.88%
2023NZ-$188.67-8.14%
2022NZ-$205.3992.67%
2021NZ-$106.60-80.33%
2020NZ-$541.89-35.11%
2019NZ-$835.05-38.96%
2018NZ-$1,368-6.1%
2017NZ-$1,45736.67%
2016NZ-$1,06633.33%
2015NZ-$799.5250%
2014NZ-$533.01-53.85%
2013NZ-$1,155-7.14%
2012NZ-$1,244-64.1%
2011NZ-$3,46577.27%
2010NZ-$1,954144.44%
2009NZ-$799.5212.93%
2008NZ-$707.9912.2%
2007NZ-$631.00

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.52-1,264.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Genocea Biosciences
GNCA
NZ-$0.92-30.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
NZ-$11.90 793.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ-$6.11 358.67%๐Ÿ‡บ๐Ÿ‡ธ USA